Press release -

Oversubscribed private placement - total €10,5 Million (100 MNOK) in ConceptoMed AS

The Board of Directors of ConceptoMed AS announce the final completion of the successful private placement of equity in ConceptoMed AS for the period January-February 2016. The placement round was oversubscribed.

ConceptoMed have been granted CE mark approval for Luer-Jack, launched the product in Europe, and so far announced exclusive distribution agreements for 11 countries in Europe and the Middle East Region.

Gross proceeds from the January-February 2016 private placement rounds amounts to NOK 100 Million (€10,4 Million), whereof approx. NOK 26 Million were subscribed by existing shareholders.

This private placement will finance the global market introduction and further growth.

ConceptoMed is committed to pursue global distribution, and to offer an innovative addition to the traditional medical disposable syringe worldwide. We are now searching for additional eager-to-grow distribution partners worldwide.

Related links

Topics

  • Business enterprise

Categories

  • syringes and needles market
  • needlestick
  • safety syringes
  • injection
  • healtcare worker
  • fluid transfer
  • technology
  • luer-jack

ConceptoMed is a rising Medtech star with innovative product categories, unique patent protected Medtech technology and strong finances. We develop and commercialize smart Medtech solutions for an international market. Excellence through Simplicity! We are brave, curious, dedicated and open-minded. Based in Norway, the team is continuously meeting milestones and expanding its activities for International growth.

For more information on the company and career opportunities, see www.conceptomed.com. Follow us on MyNewsdesk and LinkedIn.

Contacts

Christian Mide

Press contact CEO +47 95 100720

Related media

Oversubscribed private placement - total €10,5 Million (100 MNOK) in ConceptoMed AS
  • Oversubscribed private placement - total €10,5 Million (100 MNOK) in ConceptoMed AS
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • File format: .pdf
Download
  • Oversubscribed private placement - total €10,5 Million (100 MNOK) in ConceptoMed AS
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • File format: .docx
Download

Related content

Luer-Jack Lock patent granted - unscrewing with one hand!

The UK Intellectual Property Office granted 2nd of March 2016 the UK patent for Luer-Jack Lock. The patent is the frontrunner for similar filed applications (pending) in all important markets world wide and is a fundamental member of the Luer-Jack patent family, ensuring a very simple one-hand operated release of connections for different fluid transfer applications.

US Patent issued for Luer-Jack®

On the 10th of May 2016, the United States Patent and Trademark office issued an official document granting the US patent for Luer-Jack. The US Luer-Jack patent is an important part of the families of similar filed applications in all important markets world wide, and is a fundamental member of the Luer-Jack patent family.

ConceptoMed named in Disrupt 100 - Index of Disruptive Businesses Worldwide

ConceptoMed proudly announce being named in the Disrupt 100 - a bi-annual Tällt Ventures publication celebrating the businesses with the most potential to influence, change or create new global markets. ConceptoMed were selected from over 1 million global startups and corporate ventures and judged by a selection of global brands.

Luer-Jack high-volume production agreement with AB Euroform MediPharm, Sweden

On the 28th of October 2016, ConceptoMed and AB Euroform MediPharm entered into an agreement for high-volume capacity manufacturing for Luer-Jack. Euroform MediPharm is a ISO 13485 certified long-term partner within development and production of polymer products for world class customers in Pharmaceutical and Medical Technology industries.

Luer-Jack featured on Front Page of the Major Norwegian Business Newspaper "Dagens Næringsliv"

Wednesday 27th of January 2016, the Major Norwegian Business Newspaper "Dagens Næringsliv" featured Luer-Jack alongside with strong recommendations from the clinical side in a two-page article.

Medtech - Private Placement of €9,4 Million in ConceptoMed AS

The Board of Directors of ConceptoMed AS announce the private placement of equity in ConceptoMed AS. Following the share issue, the number of Shareholders in the company amounts to 73 (previously 37). Gross proceeds from the private placement amounts to NOK 89.056.000 (approx. 9,4 MEUR), whereof 25,5 MNOK were subscribed by existing shareholders.

ConceptoMed with Global IPR strategy + Dehns​ Patent and Trade Mark Attorneys

Since April 2012, Dehns has drafted and filed over 50 patent applications across 8 families, as well as a number of design registrations and trade marks. Patents have so far been granted in 4 families, and applications are pending in a number of territories including UK & Europe, PCT, USA, Brazil, Argentina, Australia, China, Hong Kong, India, South Korea, Singapore, Japan, Mexico, and Russia.